Get started
Author

Daniel Bsteh

Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing
2019 · Hagar F. Moussa, Daniel Bsteh, et al. · Nature Communications · 74
PDF
Parallel PRC2/cPRC1 and vPRC1 pathways silence lineage-specific genes and maintain self-renewal in mouse embryonic stem cells
2020 · J. A. Zepeda-Martinez, C. Pribitzer, et al. · Science Advances · 61
PDF
Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7
2019 · Kelsey N. Lamb, Daniel Bsteh, et al. · Cell chemical biology · 59
PDF
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer
2024 · Amir Goldkorn, Catherine Tangen, et al. · JAMA Network Open · 46
Reprogramming CBX8-PRC1 function with a positive allosteric modulator
2021 · Junghyun L. Suh, Daniel Bsteh, et al. · Cell chemical biology · 25
PDF
Loss of cohesin regulator PDS5A reveals repressive role of Polycomb loops
2023 · Daniel Bsteh, Hagar F. Moussa, et al. · Nature Communications · 20
PDF
m6A epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer
2023 · Emmanuelle Hodara, Aubree Mades, et al. · NAR Cancer · 13
PDF
Discovery and Characterization of a Cellularly Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7
2019 · Kelsey N. Lamb, Daniel Bsteh, et al. · SSRN Electronic Journal · 3
Baseline circulating tumor cell (CTC) count as a prognostic marker of overall survival (OS) in metastatic hormone sensitive prostate cancer (mHSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide.
2023 · Amir Goldkorn, Catherine Tangen, et al. · Journal of Clinical Oncology · 2
Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).
2025 · Daniel Bsteh, Jonathan Buckley, et al. · Journal of Clinical Oncology · 1
Combined Transcriptomic and Epitranscriptomic Profiling Identifies THBS1 as A Regulator of Enzalutamide Resistance in Prostate Cancer
2025 · Emmanuelle Hodara, Lisa Swartz, et al. · Cancer Heterogeneity and Plasticity · 1
PDF
Circulating Microbial DNA as a Potential Cancer Biomarker: Technical Challenges and Controlled Evaluation
2026 · Daisy Fry Brumit, Daniel Bsteh, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Noninvasive fragmentomic profiling of plasma cell-free DNA (cfDNA) in metastatic prostate cancer (mPC): Associations with transcriptomic phenotypes and disease states.
2026 · Daniel Bsteh, Zexun Wu, et al. · Journal of Clinical Oncology
Abstract LB259: Development of a CTC based assay to characterize MAOA expression in metastatic prostate cancer
2025 · Daniel Bsteh, Caelin Brenninkmeijer, et al. · Cancer Research
HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).
2023 · Daniel Bsteh, Jonathan Buckley, et al. · Journal of Clinical Oncology
PDF
Works count: 15
Citation count: 305
H-index: 7
I10-index: 7
Year
Topic
Type